A SMART data analysis method for constructing adaptive treatment strategies for substance use disorders.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 28029718.
- Also identified by DOI 10.1111/add.13743 and PMC identifier 5431579.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To demonstrate how Q-learning, a novel data analysis method, can be used with data from a sequential, multiple assignment, randomized trial (SMART) to construct empirically an adaptive treatment strategy (ATS) that is more tailored than the ATSs already embedded in a SMART. We use Q-learning with data from the Extending Treatment Effectiveness of Naltrexone (ExTENd) SMART (N = 250) to construct empirically an ATS employing naltrexone, behavioral intervention, and telephone disease management to reduce alcohol consumption over 24 weeks in alcohol dependent individuals. Q-learning helped to identify a subset of individuals who, despite showing early signs of response to naltrexone, require additional treatment to maintain progress. Q-learning can inform the development of more cost-effective, adaptive treatment strategies for treating substance use disorders.
Medical subject headings
- Adaptive Clinical Trials as Topic
- Alcoholism
- Behavior Therapy
- Data Interpretation, Statistical
- Naltrexone
- Narcotic Antagonists
- Randomized Controlled Trials as Topic